Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 8, 2026
The status of health-related quality of life among older adults with overactive bladder: a cross-sectional analysis of the Yamagata Cohort Study in JapanNorihiko Tsuchiya, Mayu Yagi, Hayato Nishida, et al.
Clinical Transplantation|February 27, 2023
Anti-human leukocyte antigen and anti-ABO antibodies after SARS-CoV-2 mRNA vaccination in kidney transplant recipientsHayato Nishida, Satoshi Takai, Hiromi Ito, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 3, 2013
[Extracorporeal partial nephrectomy and auto-transplantation after presurgical targeted therapy with tyrosine kinase inhibitors for renal cell cancer]Hayato Nishida, Hidenori Kanno, Noriyuki Hosoya, et al.
BMC Cancer|August 22, 2025
Metabolic landscape of clear cell renal cell carcinoma and search for metabolites predictive of drug responseMichinobu Ozawa, Sei Naito, Hideki Makinoshima, et al.
Clinical and Experimental Nephrology|July 3, 2021
Adjuvant heparinization before manipulation of artery reduces early failure in primary arteriovenous fistula for end-stage renal disease patientsHayato Nishida, Hiroki Fukuhara, Takaaki Nawano, et al.
Transplantation Proceedings|January 25, 2022
Outcomes of Living Kidney Transplantation for Mitochondrial Disease Patients: A Case SeriesHayato Nishida, Takaaki Nawano, Hiroki Fukuhara, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
A Multicenter Retrospective Study of Avelumab First-Line Maintenance and Subsequent Therapies for Locally Advanced and Metastatic Urothelial Carcinoma: Subgroup Analysis of First-Line Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, and Gemcitabine Plus Cisplatin in the Japan AVElumab MAintenance and Continuous Treatment Study (JAVEMACS)Masaomi Ikeda, Kiyohide Fujimoto, Noriyoshi Miura, et al.
BMC Cancer|January 23, 2025
Real-world short-term outcomes and treatment regimen comparisons in patients with metastatic renal cell carcinoma treated with first-line immune combinationsMasato Kikuta, Sei Naito, Takahiro Osawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 24, 2024
Urinary continence outcomes after robot-assisted laparoscopic radical prostatectomy: Significance of anterior reconstructionKeisuke Funajima, Sei Naito, Atsushi Fukai, et al.
International Journal of Oncology|June 26, 2026
Stress‑induced catecholamines attenuate sorafenib efficacy by inhibiting ferroptosis in β2‑adrenergic receptor positive renal cell carcinomaMasaki Ushijima, Sei Naito, Hiromi Ito, et al.
Pageof 10